文献速递认知障碍与痴呆

80岁及以上无痴呆个体中β-淀粉样蛋白沉积与新发痴呆的关联

Association Between β-Amyloid Accumulation and Incident Dementia in Individuals 80 Years or Older Without Dementia.
PubMed 文献 · Neurology · 2023-12-22

研究纳入94例85.9±2.8岁无痴呆个体,2009至2020年间最多行5次PiB-PET和临床评估,并与120例80岁以下无痴呆个体比较。所有参与者Aβ沉积逐渐增加,基线Aβ负荷、皮层厚度和白质病变体积是新发痴呆的预测因素,短期Aβ沉积变化与新发痴呆无显著关联。老年队列Aβ累积速度更快(5.6%/年 vs 4.1%/年,p=0.01)。

要点

  • 80岁以上无痴呆个体Aβ沉积速率为5.6%/年,快于80岁以下者的4.1%/年(p=0.01)。
  • 基线Aβ负荷、皮层厚度和白质病变体积是新发痴呆的预测因素。

核心结论

  • 80岁以上认知正常个体Aβ累积加速,基线Aβ沉积是新发痴呆和短期Aβ沉积变化的决定因素,提示这些参与者认知正常时已存在活跃的Aβ病理过程,年龄可能不是使用新兴抗Aβ疗法的限制因素。

研究设计与样本

  • 研究纳入94例无痴呆参与者(年龄85.9±2.8岁),2009至2020年间行最多5次PiB-PET和临床评估,其中94例有2次PiB-PET扫描、76例有3次、18例有4次、10例有5次。
  • 将Aβ沉积速率与澳大利亚影像、生物标志物和生活方式(AIBL)研究中120例80岁以下无痴呆个体(69.3±5.4岁)比较,后者有3次或以上年度PiB-PET评估。

主要发现

  • 至2020年,49%的参与者发生痴呆,63%死亡。
  • 所有参与者无论基线Aβ阳性或阴性,Aβ沉积均逐渐增加。
  • 基线Aβ负荷、皮层厚度和白质病变体积是新发痴呆的预测因素。
  • 老年队列Aβ累积速度(5.6%/年)快于AIBL队列(4.1%/年),p=0.01;基线Aβ沉积是短期变化(平均时间1.88年)的预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: While the highest prevalence of dementia occurs in individuals older than 80 years, most imaging studies focused on younger populations. The rates of β-amyloid (Aβ) accumulation and the effect of Alzheimer disease (AD) pathology on progression to dementia in this age group remain unexplored. In this study, we examined the relationship between changes in Aβ deposition over time and incident dementia in nondemented individuals followed during a period of 11 years. METHODS: We examined 94 participants (age 85.9 + 2.8 years) who had up to 5 measurements of Pittsburgh compound-B (PiB)-PET and clinical evaluations from 2009 to 2020. All 94 participants had 2 PiB-PET scans, 76 participants had 3 PiB-PET scans, 18 participants had 4 PiB-PET scans, and 10 participants had 5 PiB-PET scans. The rates of Aβ deposition were compared with 120 nondemented individuals younger than 80 years (69.3 ± 5.4 years) from the Australian Imaging, Biomarker, and Lifestyle (AIBL) study who had 3 or more annual PiB-PET assessments. RESULTS: By 2020, 49% of the participants developed dementia and 63% were deceased. There was a gradual increase in Aβ deposition in all participants whether they were considered Aβ positive or negative at baseline. In a Cox model controlled for age, sex, education level, APOE-4 allele, baseline Mini-Mental State Examination, and mortality, short-term change in Aβ deposition was not significantly associated with incident dementia (HR 2.19 (0.41-11.73). However, baseline Aβ burden, cortical thickness, and white matter lesions volume were the predictors of incident dementia. Aβ accumulation was faster (p = 0.01) in the older cohort (5.6%/year) when compared with AIBL (4.1%/year). In addition, baseline Aβ deposition was a predictor of short-term change (mean time 1.88 years). DISCUSSION: There was an accelerated Aβ accumulation in cognitively normal individuals older than 80 years. Baseline Aβ deposition was a determinant of incident dementia and short-term change in Aβ deposition suggesting that an active Aβ pathologic process was present when these participants were cognitively normal. Consequently, age may not be a limiting factor for the use of the emergent anti-Aβ therapies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Lopez OL, Villemagne VL, Chang YF, et al. Association Between β-Amyloid Accumulation and Incident Dementia in Individuals 80 Years or Older Without Dementia. Neurology. 2023. PMID: 38165336. doi:10.1212/WNL.0000000000207920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。